TNFSF13 and lupus nephritis: Hydroxychloroquine, now standard of care for lupus nephritis, may also be effective in IgAN by inhibiting Toll-like receptor-9 upregulation of BAFF/APRIL and cytokine production, as well as by inhibiting antigen processing by antigen-presenting cells.